IvanRychlik Charles University, Third Faculty of Medicine, Department of Internal MedicineCzech Republic

IvanRychlik
Institution

Day 1 - Sunday April 14, 2024

Time Session
9 a.m.
10:30 a.m.
Hands on Big Data Mining for the Nephrologist in 2024
HeatherAscani Chairperson University of MichiganUnited States
KatherineTuttle Chairperson University of Washington School of Medicine, Division of NephrologyUnited States
MatthiasKretzler Chairperson University of MichiganUnited State
  • Looking for Data on Glomerular Diseases: How to Find the Treasures You Are Looking for With a Click of a Mouse
    VijiNair Speaker University of MichiganUnited States
  • Open Science in an Open Community: Resources of the Kidney Precision Medicine Project for CKD and AKI
    MatthiasKretzler Speaker University of MichiganUnited State
  • The Future is Now: How to Mine Cells and Neighborhoods of the Kidney in Health and Disease
    JulioSaez-Rodriguez Speaker julio.saez@uni-heidelberg.deHeidelberg UniversityGermany
  • Panel Discussion
Hall C1
Population Health and Strategies to Protect the Fragile
EnriqueDorado Chairperson egdorado@gmail.comInstituto de Investigaciones Médicas "A. Lanari". Universidad de Buenos AiresArgentina
ShokoufehSavaj Chairperson ssavaj@hotmail.comIran
  • Being Born Too Small: What a Nephrologist Should Know to Support Prevention of CKD in Future Generations
    DanieleTrevisanuto Speaker daniele.trevisanuto@unipd.itUniversity Hospital of Padova, ItalyItaly
  • Hypertensive Disorders of Pregnancy as a Means to Discover CKD
    Giorgina BarbaraPiccoli Speaker Centre Hospitalier Le MansFrance
  • Managing Pregnancy with Advanced CKD in a Limited-resource Setting
    AlejandraOrozco Guillen Speaker ale_gaba@hotmail.comNational Institute of Perinatology, Nephrology depMexico
  • Pre-eclampsia and its Differential Diagnosis: A Viewpoint from LMICs
    RashaShemies Speaker rashasamirtaha@gmail.comMansoura UniversityEgypt
  • Q and A
Hall D
2:45 p.m.
3:30 p.m.
What is ongoing in CKDu around the world? - CKDU interactive discussions (ISN i3C)
ErangaWijewickrama Spotlight Chairperson Faculty of Medicine, University of ColomboSri Lanka
Jose VicenteSanchez Polo Spotlight Chairperson visanpolo@gmail.comRenal Division Social Security Institute. Nephrology Residence Program Coordinator, San Carlos University School of Medicine. Latin-American Society Of Nephrology (SLANH)Guatemala
Magdalena Madero Spotlight Speaker Chief of Nephrology, Instituto Nacional de CardiolMexico
VivekanandJha Spotlight Speaker vjha@georgeinstitute.org.inGeorge Institute for Global Health IndiaIndia
NishanthaNanyakkara Spotlight Speaker nishantha4313@gmail.comSri Lanka
Spotlight Stage 1 (exhibition hall)
4 p.m.
4:30 p.m.
Potential Role of Anti-CD38 Therapy in Autoimmune Kidney Diseases like Lupus Nephritis
BradRovin Spotlight Speaker The Ohio State UniversityUnited States
UptalPatel Spotlight Speaker uptal@hibio.comUnited States
Spotlight Stage 1 (exhibition hall)
4:30 p.m.
5:30 p.m.
New Developments in CKD Epidemiology Research
MaartenTaal Chairperson University of NottinghamUnited Kingdom
RobertoPecoits Filho Chairperson Arbor Research Collaborative for HealthUnited States
  • Big Data Lab
  • Patient-reported Outcome Measures: How Do Patients Experience CKD?
    AdeeraLevin Speaker University of British Columbia and Providence Health CareCanada
  • Trial Simulation Using Observational Data
    AngeloKaraboyas Speaker angelo.karaboyas@arborresearch.orgArbor Research Collaborative for HealthUnited States
  • Using Routinely Collected Big Datasets for Clinical Research in CKD: Opportunities and Challenges
    DorotheaNitsch Speaker dorothea.nitsch@lshtm.ac.ukLondon School of Hygiene & Tropical MedicineUnited Kingdom
  • Q and A
Hall C4

Day 2 - Monday April 15, 2024

Time Session
11 a.m.
12 p.m.
Plenary Session 3: Generative AI Revolution in Medicine (Michal Rosen-Zvi, Israel)
Jose VicenteSanchez Polo Chairperson visanpolo@gmail.comRenal Division Social Security Institute. Nephrology Residence Program Coordinator, San Carlos University School of Medicine. Latin-American Society Of Nephrology (SLANH)Guatemala
MegJardine Chairperson NHMRC Clinical Trials Centre, University of Sydney, AustraliaAustralia
  • Generative AI Revolution in Medicine
    MichalRosen-Zvi Speaker ROSEN@il.ibm.comhttps://research.ibm.com/Israel
  • Acceptance Speech by Awardee (Schrier Award), with Tasnuva Sarah Kashem (UK) and Farnaz Nobi (Bangladesh)
    Mohammad Shakib Uz ZamanArefin Speaker shakib04@yahoo.comBangladesh
Hall A
12:15 p.m.
1:15 p.m.
It
AlejandraOrozco Guillen Chairperson ale_gaba@hotmail.comNational Institute of Perinatology, Nephrology depMexico
IvanRychlik Chairperson ivan.rychlik@fnkv.czCharles University, Third Faculty of Medicine, Department of Internal MedicineCzech Republic
Rita MarcelaFortunato Chairperson marcelafortunator@gmail.comFundacion Favaloro University Hospital, Faculty of Medicine, University of Buenos AiresArgentina
  • Women and
    UrmilaAnandh Speaker uanandh@gmail.comAmrita Hospitals, Faridabad, Delhi NCRIndia
  • Pregnancy and CKD
    Prof LizLightstone Speaker Imperial College LondonUnited Kingdom
  • Pregnancy and Transplantation
    SilviShah Speaker University of Cincinnati, Ohio, United StatesUnited States
  • Global and African Epidemiology, Management and Outcomes of CKD and dialysis in Men and Women: A Perspective on Gender Disparities
    RashaDarwish Speaker Kasr Aleiny medical school , Cairo UniversityEgypt
  • Q and A
Hall C4
3 p.m.
4 p.m.
Treatment Goals for Severe Hyponatremia: A Debate on Current Guidelines Program
MitchellRosner Chairperson Univeristy of Virginia HealthUnited States
  • Overview of Hyponatremia
    Angela Yee-MoonWang Speaker Hong Kong/SingaporeSingapore
  • Pro: Current Guidelines are Appropriate
    HelbertRondon-Berrios Speaker rondonberriosh@upmc.eduUniversity of Pittsburgh School of MedicineUnited States
  • Con: Current Guidelines are Too Conservative
    CarlosAyus Speaker carlosayus@yahoo.comUniversity of California IrvineUnited States
  • Discussion
Hall C3
4:30 p.m.
5:30 p.m.
Paraproteinemia and the Kidney
CarolineLamarche Chairperson caroline.lamarche.1@umontreal.caUniversité de MontréalCanada
Gustavo CristianGreloni Chairperson gustavo.greloni@hospitalitaliano.org.arArgentina
  • MGRS: Should All Forms Need Clonal Therapy?
    FrankBridoux Speaker f.bridoux@chu-poitiers.frDepartment of Nephrology and French Reference Center for AL amyloidosis and MGRS, University Hospital, Poitiers, FranceFrance
  • Renal Amyloidosis: What Is New?
    Veronica Torres CostaSilva Speaker veronica.torres@hc.fm.usp.brSão Paulo State Cancer Institute - University of São PauloBrazil
  • Can We Perform a Transplant in Patients with Myeloma and Amyloidosis?
    SabineKaram Speaker sabinejkaram@gmail.comUniversity of MinnesotaUnited States
  • Q and A
Hall A

Day 3 - Tuesday April 16, 2024

Time Session
9 a.m.
10 a.m.
Type 2 Diabetes in Kidney Disease: Recent Updates and Best Practices for Detection and Treatment
DebasishBanerjee Chairperson dbanerje@sgul.ac.ukSt George's University Hospital NHS Foundation TrUnited Kingdom
MegJardine Chairperson NHMRC Clinical Trials Centre, University of Sydney, AustraliaAustralia
  • Setting the Scene
    MegJardine Speaker NHMRC Clinical Trials Centre, University of Sydney, AustraliaAustralia
  • DM and CKD: Which Treatment Should I Use for Different Populations?
    KatherineTuttle Speaker University of Washington School of Medicine, Division of NephrologyUnited States
  • How to Design Studies on Answering Unanswered Questions
    VladoPerkovic Speaker vlado.perkovic@unsw.edu.auUniversity of New South Wales, Sydney, AustraliaAustralia
  • The Effect of SGLT2 Inhibitors in Patients with Chronic Kidney Disease, With or Without Type 2 Diabetes
    DavidWheeler Speaker University College LondonUnited Kingdom
  • Q and A
Hall C4